Evidence map›Paper›PMID 25673636›Full record

ArticleClinical trials (London, England)2015

Clinical trial awareness: Changes over time and sociodemographic disparities.

Amanda Leiter, Michael A Diefenbach, John Doucette, William K Oh, Matthew D Galsky

Abstract read
In one paragraph

Article in Clinical trials (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Beyond Barriers: Achieving True Equity in Cancer Care.Current oncology (Toronto, Ont.) · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Recommending Clinical Trials for Online Patient Cases using Artificial Intelligence.AMIA ... Annual Symposium proceedings. AMIA Symposium · 2024
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amanda LeiterDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA Amanda.leiter@mssm.edu.
Michael A DiefenbachDepartment of Urology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
John DoucetteDepartment of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
William K OhDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Matthew D GalskyDepartment of Medicine, Division of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Funding

RCT of an Online Multimedia Program to Boost Coping & Function for Pca SurvivorsR01CA158019 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI MILLER, SUZANNE M · 2011 to 2015
$3.5M
Brief Intervention to Improve QOL & Couple Functioning after Prostate SurgeryR21CA155963 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI DIEFENBACH, MICHAEL A · 2011 to 2012
$418k
Decision Making For Active Surveillance in Prostate Cancer Patients and SpousesR21CA164807 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI DIEFENBACH, MICHAEL A, NELSON, CHRISTIAN J · 2012 to 2013
$412k
NCI NIH HHS 1R01CA158019-01NCI NIH HHS 1R21 CA155963NCI NIH HHS 1R21 CA164807NCI NIH HHS R01 CA158019NCI NIH HHS R21 CA155963NCI NIH HHS R21 CA164807
6 · The paper itself

Abstract

BACKGROUND OR

aimsLack of clinical trial awareness is a known obstacle to clinical trial enrollment. We sought to define the prevalence of clinical trial awareness in the US population, determine characteristics associated with increased trial awareness, and explore potential disparities in trial awareness.

methodsWe utilized data from the Health Information National Trends Survey from 2008 and 2012. Logistic regression was utilized to assess predictors of clinical trial awareness, particularly sociodemographic variables and information-seeking preferences. Trial awareness and information-seeking preferences were compared in patient subgroups and between the two time periods.

resultsClinical trial awareness increased from 68% to 74% between 2008 and 2012. In the 2012 dataset, higher education level (odds ratio: 3.52, 95% confidence interval: 2.16-5.74), higher yearly income category (odds ratio: 1.84, 95% confidence interval: 1.17-2.89), and Internet use (odds ratio: 2.13, 95% confidence interval: 1.52-3.00) were significantly associated with clinical trial awareness. Hispanic ethnicity (odds ratio: 0.41, 95% confidence interval: 0.25-0.68) was significantly associated with decreased awareness. Clinical trial awareness increased in African-American/Blacks (Δ10.6%) and Hispanics (Δ10.7%) between 2008 and 2012, as did Internet use in both subgroups (Δ14.2%, Δ18.1%, respectively).

conclusionOverall clinical trial awareness has increased between 2008 and 2012, although a large subset of the population still lacks general awareness of clinical trials. Racial and ethnic disparities in trial awareness exist, although disparities may be decreasing among the Black population. These findings may help target educational efforts and inform approaches to increasing trial awareness.

Indexed as

AwarenessHealth Knowledge, Attitudes, PracticeAdolescentAdultAgedAged, 80 and overClinical Trials as TopicEthnicityFemaleHumansMaleMiddle AgedRacial GroupsResearch SubjectsSocioeconomic FactorsUnited StatesClinical trial awarenessclinical trial barriersclinical trial disparitieshealth communicationhealth informationInternetnational cross-sectional survey

Identifiers

PMID25673636
PMCPMC4667750

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.